STAT3 and Parkinson disease: Pharmacological inhibition of JAK2 in MPTP mouse model of PD can significantly result in the decrease of pSTAT3 and GFAP expression levels and reactivity of astrocytes, suggesting that the JAK/STAT3 signaling pathway is required to induce reactivity of astrocytes in the diseased condition [82].